Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer

Table 1 Journals with the most published articles

Journal	Number
Journal of Proteome Research	3
Scientific Reports	3
Frontiers in Cell and Developmental Biology	2
Journal of Translational Medicine	2

Table 2 Key words with the highest frequency

Key word	Frequency
Expression	13
Progression	8
Gene	7
Survival	7
Breast cancer	6

Table 3 Most relevant authors in breast cancer and phosphoglycerate kinase 1 literature

Authors	Number of articles	Articles fractionalized
Zhang X	5	0.84
Jiang Y	5	0.47
Wang J	4	0.73
Li Y	4	0.59
Aryal UK	3	0.62
Mittal L	3	0.62
Sundararajan R	3	0.62
Lu Z	3	0.28
Liang Y	2	0.50
Ye T	2	0.50

Table 4 Top authors by H-index in breast cancer and phosphoglycerate kinase 1 literature

Authors	H-index	G-index	M-index	Total citations	Number of publications	Publication year
Jiang Y	3	4	0.375	256	4	2015
Zhang X	3	4	0.375	79	4	2015
Wang J	3	4	0.250	35	4	2011
Aryal UK	3	3	0.750	42	3	2019
Mittal L	3	3	0.750	42	3	2019
Sundararajan R	3	3	0.750	42	3	2019
Li Y	2	3	0.500	53	3	2019
Camarillo IG	2	2	0.667	27	2	2020
Liang Y	2	2	0.667	15	2	2020
Ye T	2	2	0.667	15	2	2020

Table 5 Most cited documents in breast cancer and phosphoglycerate kinase 1 literature

Ref.	Journal	DOI	Local citations	Global citations
Zhang et al[44], 2005	Mol Cell Proteomics	10.1074/mcp.M400221-MCP200	9	244
Shashni et al[47], 2013	J Drug Target	10.3109/1061186X.2012.736998	4	33
Qian et al[48], 2017	Mol Cell	10.1016/j.molcel.2017.01.027	3	133
Kabbage et al[53], 2008	J Biomed Biotechnol	10.1155/2008/564127	2	25
Fu et al[35], 2018	Life Sci	10.1016/j.lfs.2020.117863	2	11

Table 6 Most cited sources of breast cancer and phosphoglycerate kinase 1 research

Sources	Number of articles
Cancer Research	96
Journal of Biological Chemistry	65
Proceedings of the National Academy of Sciences of the United States of America	38
Clinical Cancer Research	36
Cell	35

Table 7 Included data sets for triple-negative breast cancer tissue vs non-cancerous breast tissue

ID	Series
GPL1390	GSE10885-GPL1390, GSE10886, GSE10893-GPL1390		GSE1992-GPL1390, GSE2607-GPL1390, GSE6128
GPL13607	GSE59246		GSE70951-GPL13607
GPL17077	GSE57297		GSE80754
GPL17586	GSE115144	GSE73540	GSE76250	GSE134359
GPL570	GSE20711	GSE50567	GSE22544	GSE146558
	GSE45827	GSE61304	GSE25407	GSE103865
	GSE65194	GSE42568	GSE26910	GSE153796
	GSE29431	GSE5764	GSE54002	GSE135565
	GSE7904	GSE10780	GSE71053	GSE7307
	GSE31448	GSE10810	GSE147472	GSE3744
	GSE29044	GSE21422	GSE140494
GPL6244	GSE36295	GSE61724		GSE118432
	GSE86374	GSE37751		GSE81838
GPL6848	GSE26304		GSE18672
GPL8269	GSE22384-GPL8269		GSE41119
GPL887	GSE10885-GPL887		GSE24124
	GSE2607-GPL887		GSE9309
GPL96	GSE15852	GSE5364	GSE158309	GSE6883-GPL96
GSE29174
GSE41970-GPL16299
GSE50428
GSE64790
GSE92252
TCGA_TNBC

TNBC: Triple-negative breast cancer.

Table 8 Included data sets for triple-negative breast cancer tissue vs non- triple-negative breast cancer tissue

ID	Series
GPL1390	GSE10885-GPL1390
GPL13607	GSE59246
GPL17077	GSE57297
GPL17586	GSE115144
GPL570	GSE20711	GSE29044	GSE10810	GSE54002	GSE103865
	GSE45827	GSE50567	GSE21422	GSE71053	GSE153796
	GSE65194	GSE61304	GSE22544	GSE147472	GSE135565
	GSE29431	GSE42568	GSE25407	GSE140494	GSE7307
	GSE7904	GSE5764	GSE26910	GSE146558	GSE3744
	GSE31448	GSE10780
GPL6244	GSE36295
GPL6848	GSE26304
GPL8269	GSE22384-GPL8269
GPL887	GSE10885-GPL887
GPL96	GSE15852
GSE148425
GSE29174
GSE50428
METABRIC_mRNA_Zscores
TCGA TNBC-nonTNBC

TNBC: Triple-negative breast cancer.